Quality meat, salt, and pepper is all we add to our simple burger recipe. Weâve tried adding extras â olive oil, cream, mustard and grated onion to name a few. While we liked some, none were as good as simply seasoned hamburger burger patties cooked in a little butter.
Now, a new study finds there are three different approaches to reverse the action of one new blood thinner, apixaban (Eliquis) -- a drug that's currently under review by the U.S. Federal Drug Administration. Researchers in Spain noted that it remains unclear which method for reversing this new drug might be best.
Apixaban, sold under the tradename Eliquis, is an anticoagulant for the treatment of venous thromboembolic events. It is taken by mouth. It is a direct factor Xa inhibitor. Apixaban was approved in Europe in 2012. It was approved in the U.S. in 2014 for treatment and secondary prophylaxis of deep vein thrombosis (DVT) and pulmonary embolism (PE). It was developed in a joint venture by Pfizer and Bristol-Myers Squibb.